Company Search:
Advanced Search
Sponsored Links
Portola Pharmaceuticals Inc Company Snapshot
Portola Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Portola Pharmaceuticals Inc with three other companies in this sector in the United States: Pfenex Inc (2015 sales of $9.58 million of which 100% was Biotechnology), bluebird bio Inc ($14.08 million of which 100% was Biological Products), and Blueprint Medicines Corp ($11.40 million of which 100% was Biopharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at Portola Pharmaceuticals Inc were $12.07 million. This is an increase of 25.4% versus 2014, when the company's sales were $9.63 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Portola Pharmaceuticals Inc
  Stock Performance Chart for Portola Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 20.69
(Figures in U.S. Dollars)
1 Week -3.0%   13 Weeks -12.3%  
4 Weeks -8.1%   52 Weeks -55.8%  
Portola Pharmaceuticals Inc Key Data:
  Ticker: PTLA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 12,070,000
(Year Ending Jan 2016).
Employees: 137
  Currency: U.S. Dollars Market Cap: 1,169,006,145
  Fiscal Yr Ends: December Shares Outstanding: 56,501,022
  Share Type: Common Closely Held Shares: 311,807
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.